Literature DB >> 22688845

Treatment adherence and blood pressure control in older individuals with hypertension.

Rachel G Bastos-Barbosa1, Eduardo Ferriolli, Julio C Moriguti, Charlys B Nogueira, Fernando Nobre, Julieta Ueta, Nereida K C Lima.   

Abstract

BACKGROUND: Non-adherence to treatment has been identified as the main cause of uncontrolled blood pressure (BP), and may represent a greater risk in older individuals.
OBJECTIVE: The aim of this study was to evaluate and compare the rate of adherence to hypertension treatment using different methods, to estimate the BP control rate, and to observe if there is an association between BP control and adherence.
METHODS: Treatment adherence was evaluated in older patients with hypertension, followed by the public primary health care, through four methods, including the Morisky-Green test (reference), the Attitude regarding the Medication Intake questionnaire (AMI), an evaluation of adherence by the nurse in the office (Nurse Adherence Evaluation - NAE), and at home (Home Adherence Evaluation - HAE). Salt intake was estimated by 24-hour sodium urinary excretion. BP control was assessed by the awake ambulatory blood pressure monitoring.
RESULTS: Concordance between the Morisky-Green test and AMI (Kappa=0.27) or NAE (Kappa=0.05) was poor. There was a moderate concordance between the Morisky-Green test and HAE. Eighty percent had controlled BP, including 42% with white-coat effect. The group with lower salt excretion informed to avoid salt intake more times (p<0.001) and had better medication adherence (p<0.001) than the higher salt excretion group.
CONCLUSION: The evaluated tests did not show a good concordance to the Morisky-Green test. Adherence to hypertension treatment was low; however, there was a high rate of BP control when subjects with the white-coat effect were included in the analysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22688845     DOI: 10.1590/s0066-782x2012005000054

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  7 in total

1.  Comparing medication adherence tools scores and number of controlled diseases among low literacy patients discharged from a Brazilian cardiology ward.

Authors:  Patrícia Carvalho Baruel Okumura; Lucas Miyake Okumura; Wálleri Christini Torelli Reis; Rangel Ray Godoy; Bianca de Oliveira Cata-Preta; Thais Teles de Souza; Maria Luiza Drechsel Fávero; Cassyano Januário Correr
Journal:  Int J Clin Pharm       Date:  2016-11-05

2.  Uncontrolled hypertension in older patients: markers and associated factors to masked and white-coat effect.

Authors:  Nereida Kc Lima; Julio C Moriguti; Eduardo Ferriolli
Journal:  J Geriatr Cardiol       Date:  2016-08       Impact factor: 3.327

3.  Blood Pressure Treatment Adherence and Control after Participation in the ReHOT.

Authors:  Nathália Silva de Jesus; Armando da Rocha Nogueira; Cacilda Oliveira Pachu; Ronir Raggio Luiz; Glaucia Maria Moraes de Oliveira
Journal:  Arq Bras Cardiol       Date:  2016-11       Impact factor: 2.000

4.  Impact of changes in pill appearance in the adherence to angiotensin receptor blockers and in the blood pressure levels: a retrospective cohort study.

Authors:  B Lumbreras; E López-Pintor
Journal:  BMJ Open       Date:  2017-03-30       Impact factor: 2.692

Review 5.  Hypertension control in brazilian publications.

Authors:  Natália de Alencar Pinho; Angela Maria Geraldo Pierin
Journal:  Arq Bras Cardiol       Date:  2013-09       Impact factor: 2.000

6.  Factors associated with hospital admissions due to hypertension.

Authors:  Rosimery Cruz de Oliveira Dantas; João Paulo Teixeira da Silva; Davidson Cruz de Oliveira Dantas; Ângelo Giuseppe Roncalli
Journal:  Einstein (Sao Paulo)       Date:  2018-09-21

7.  Chronic stress as a mediator of the relationship between socioeconomic status and pharmacological adherence in hypertensive patients

Authors:  Deivis Nicolás Guzmán-Tordecilla; Andrés Ignacio Vecino-Ortiz; Diego Lucumí; Graciela Mentz
Journal:  Biomedica       Date:  2020-06-15       Impact factor: 0.935

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.